Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Query: "AREA[SponsorSearch](Pharmaceutical Product Development, LLC)"
Count: 51
Selected: 0
NCT03354273An International Study to Evaluate Diagnostic Efficacy of Flurpiridaz (18F) Injection PET MPI in the Detection of Coronary Artery Disease (CAD)
NCT03915886A Study of JNJ-64530440 in Healthy Japanese Male Participants
NCT02342249Study of Acute Uncomplicated Seasonal Influenza A in Adult Subjects
NCT04117113Study to Collect Information About Invasive Disease Caused by Extraintestinal Pathogenic Escherichia Coli-2 (EXPECT-2)
NCT04087681Study to Collect Information About Invasive Disease Caused by Extraintestinal Pathogenic Escherichia Coli (EXPECT-1)
NCT00127881Study of Human Monoclonal Antibody to Treat Mycosis Fungoides and Sezary Syndrome
NCT03332485Safety and Efficacy Study of an Edible Colonoscopy Preparation
NCT01154335Everolimus and OSI-906 for Patients With Refractory Metastatic Colorectal Cancer
NCT00193232Weekly Docetaxel and Bortezomib in the Treatment of Advanced Hormone-Refractory Prostate Cancer
NCT00193323Weekly Docetaxel Versus Weekly Docetaxel/Gemcitabine in the Treatment of Non-Small Cell Lung Cancer in Elderly Patients
NCT00193271Adjuvant Docetaxel and Estramustine Phosphate for High Risk Localized Prostate Cancer
NCT00193115Docetaxel Followed by Doxorubicin Plus Cyclophosphamide for Node Positive or High-Risk Primary Breast Cancer
NCT00193011Weekly Docetaxel and CMF in the Adjuvant Treatment of Elderly Women With High-Risk Breast Cancer
NCT02649673LCL161 Plus Topotecan for Patients With Relapsed/Refractory Small Cell Lung Cancer and Select Gynecologic Malignancies
NCT02125084Enzalutamide Plus Everolimus in Men With Metastatic Castrate-Resistant Prostate Cancer
NCT01226732A Study of the Hsp90 Inhibitor AUY922 Plus Capecitabine for the Treatment of Patients With Advanced Solid Tumors
NCT00594230LBH589 in Refractory Myelodysplastic Syndromes (MDS)
NCT04890535Evaluation of the Safety, Tolerability, PK of TBAJ-587 in Healthy Adults
NCT01871675Study of IPI-145 in Combination With Rituximab or Bendamustine/Rituximab in Hematologic Malignancies
NCT02168101Determining the Feasibility of MLN9708 as Maintenance After Allogeneic Stem Cell Transplant for Multiple Myeloma
NCT01990209Orteronel as Monotherapy in Patients With Metastatic Breast Cancer (MBC) That Expresses the Androgen Receptor (AR)
NCT00193557Weekly Bortezomib (Velcade) in the Treatment of Patients With Refractory Multiple Myeloma
NCT00193427Preoperative Therapy in Patients With Stages IB, II, IIIA, and Selected IIIB Patients With Non-Small Cell Lung Cancer
NCT00193089Docetaxel, Vinorelbine and Trastuzumab in the Treatment of Patients With Metastatic Her-2 Positive Breast Cancer
NCT00193024Epirubicin and Docetaxel in the Treatment of Patients With Metastatic Breast Cancer
NCT01027598Randomized, Double-Blind Trial of Erlotinib/Pazopanib or Erlotinib/Placebo in Patients With Previously Treated Advanced Non-Small-Cell Lung Cancer
NCT00609804Sorafenib and Erlotinib or Sorafenib Alone in Advanced Non-Small Cell Lung Cancer Progressing on Erlotinib
NCT00193284Chemotherapy Plus Gefitinib Followed by Chemotherapy, Radiation Therapy, and Gefitinib For Head and Neck Cancer
NCT00193180Docetaxel Plus Imatinib Mesylate in Metastatic Breast Cancer
NCT00193128Preoperative Therapy With Oxaliplatin/Docetaxel/Capecitabine and Radiation in Resectable Esophagus Cancer
NCT00193037Doxorubicin HCI Liposome Injection Versus Weekly Docetaxel in Patients First Relapse Metastatic Breast Cancer
NCT01056276Study to Evaluate the Combination of Bendamustine, Bortezomib and Dexamethasone (BBD) in the First-Line Treatment of Patients With Multiple Myeloma Who Are Not Candidates for High Dose Chemotherapy
NCT01029730Trial of Bendamustine, Bortezomib, and Rituximab in Patients With Previously Untreated Low Grade Lymphoma
NCT00633594Rituximab, Lenalidomide, and Bortezomib in Mantle Cell Lymphoma
NCT03129139A Phase 1, Multi-Center, Open-Label, Dose-Escalation, Safety, Pharmacokinetic, and Pharmacodynamic Study of Minnelide™ Capsules Given Alone or in Combination With Protein-Bound Paclitaxel in Patients With Advanced Solid Tumors
NCT04291664PK and Dose Escalation and Expansion Study of DST-2970
NCT00193245Oral Topotecan Versus Docetaxel in Second-Line Treatment of Non-Small Cell Lung Cancer
NCT00210496Potential Impact (Benefit) of Preventative Treatment With Topamax on the Effectiveness of Axert in the Acute Treatment of Migraine
NCT00193050Weekly Gemcitabine, Epirubicin, and Docetaxel in Locally Advanced or Inflammatory Breast Cancer
NCT01008852Study Evaluating The Efficacy And Safety Of SBI-087 In Seropositive Subjects With Active Rheumatoid Arthritis
NCT00815906Study Evaluating Single Doses Of SBI-087 In Japanese Subjects With Rheumatoid Arthritis
NCT00714116Study Evaluating The SBI-087 In Subjects With Systemic Lupus Erythematosus
NCT00641225Study Evaluating Single Doses Of SBI-087 in Subjects With Rheumatoid Arthritis
NCT00521638Study Evaluating TRU-015 in B-Cell Non-Hodgkin's Lymphoma
NCT00479622Study of TRU-015 in Subjects With Membranous Nephropathy Secondary to Systemic Lupus Erythematosus
NCT04693793Establishing Clinical Utility for a New Diagnostic Test for Patients With Shortness of Breath
NCT004755015-Alpha Reductase and Anabolic Effects of Testosterone
NCT05163080SurVaxM Plus Adjuvant Temozolomide for Newly Diagnosed Glioblastoma (SURVIVE)
NCT02795156Study Assessing Activity of Molecularly Matched Targeted Therapies in Select Tumor Types Based on Genomic Alterations
NCT01813448A Study to Assess the Safety, Tolerability and Pharmacokinetics of Single and Multiple Ascending Doses of Fidaxomicin in Healthy Male Japanese and Caucasian Subjects